Lonza Group Ag - Stock Price History | LZAGY

Historical daily share price chart and data for Lonza Group Ag since 1969 adjusted for splits. The latest closing stock price for Lonza Group Ag as of December 31, 1969 is 0.00.
  • The all-time high Lonza Group Ag stock closing price was 0.00 on December 31, 1969.
  • The Lonza Group Ag 52-week high stock price is 0.00, which is NAN% above the current share price.
  • The Lonza Group Ag 52-week low stock price is 0.00, which is NAN% below the current share price.
  • The average Lonza Group Ag stock price for the last 52 weeks is NaN.
Lonza Group Ag Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.768B $5.566B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.323B 20.26
Abbott Laboratories (ABT) United States $141.074B 26.52
Stryker (SYK) United States $79.557B 27.51
Boston Scientific (BSX) United States $52.891B 25.66
Baxter (BAX) United States $44.520B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $32.321B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.767B 17.77
Coloplast (CLPBY) Denmark $25.229B 40.28
Terumo (TRUMY) Japan $23.431B 29.24
Smith & Nephew SNATS (SNN) United Kingdom $20.446B 0.00
ResMed (RMD) United States $18.578B 35.40
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.880B 52.96
Insulet (PODD) United States $9.176B 543.75
Perrigo (PRGO) Ireland $7.218B 13.30
Hill-Rom Holdings (HRC) United States $6.641B 19.80
Canopy Growth (CGC) Canada $6.561B 0.00
Haemonetics (HAE) United States $6.400B 48.30
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.611B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.590B 0.00
Neogen (NEOG) United States $3.348B 56.02
NuVasive (NUVA) United States $3.295B 26.27
ICU Medical (ICUI) United States $3.139B 20.36
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.427B 0.00
Quidel (QDEL) United States $2.414B 23.97
Agios Pharmaceuticals (AGIO) United States $1.901B 0.00
National Vision Holdings (EYE) United States $1.871B 40.39
Cardiovascular Systems (CSII) United States $1.582B 0.00
Aphria (APHA) $1.099B 0.00
VAREX IMAGING (VREX) United States $1.093B 25.19
AtriCure (ATRC) United States $0.999B 0.00
Phibro Animal Health (PAHC) United States $0.870B 14.15
Eagle Pharmaceuticals (EGRX) United States $0.830B 21.16
NanoString Technologies (NSTG) United States $0.769B 0.00
PetIQ (PETQ) United States $0.746B 17.62
Omeros (OMER) United States $0.734B 0.00
Lantheus Holdings (LNTH) United States $0.731B 19.21
LeMaitre Vascular (LMAT) United States $0.643B 38.13
Cerus (CERS) United States $0.603B 0.00
Surmodics (SRDX) United States $0.581B 110.51
Quanterix (QTRX) United States $0.554B 0.00
MacroGenics (MGNX) United States $0.550B 0.00
TG Therapeutics (TGTX) United States $0.494B 0.00
OraSure Technologies (OSUR) United States $0.481B 22.27
Meridian Bioscience (VIVO) United States $0.404B 12.60
Owens & Minor (OMI) United States $0.392B 11.74
Zynex (ZYXI) United States $0.374B 39.69
Utah Medical Products (UTMD) United States $0.342B 25.03
BioLife Solutions (BLFS) United States $0.329B 101.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.308B 0.00
United Health Products (UEEC) United States $0.240B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.143B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.127B 8.94
InfuSystems Holdings (INFU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.098B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.086B 20.43
Nephros (NEPH) United States $0.074B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.035B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.021B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00